Pharmlog Pharma Logistik
Pharmlog Pharma Logistik, commonly referred to as Pharmlog, is a leading logistics provider in the pharmaceutical industry, headquartered in Germany. Established in 2003, the company has rapidly expanded its operations across Europe, specialising in temperature-controlled logistics and supply chain solutions tailored for the healthcare sector. Pharmlog offers a range of core services, including warehousing, distribution, and regulatory compliance, ensuring the safe and efficient delivery of pharmaceutical products. Their commitment to quality and innovation has positioned them as a trusted partner for numerous pharmaceutical companies. With a focus on maintaining the integrity of sensitive products, Pharmlog has achieved significant milestones, reinforcing its reputation as a key player in the pharmaceutical logistics market.
DitchCarbon Score
How does Pharmlog Pharma Logistik's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pharmlog Pharma Logistik's score of 29 is higher than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmlog Pharma Logistik's reported carbon emissions
In 2022, PharmLog Pharma Logistik reported total greenhouse gas emissions of approximately 6,692,000 kg CO2e. This figure includes 1,425,000 kg CO2e from Scope 1 emissions, which encompass direct emissions from owned or controlled sources, and 242,000 kg CO2e from Scope 2 emissions, related to indirect emissions from the generation of purchased electricity, steam, heating, and cooling. The company also reported significant Scope 3 emissions, amounting to approximately 6,616,000 kg CO2e, which include emissions from the entire value chain, such as purchased goods and services, business travel, and waste generated in operations. PharmLog has set ambitious climate commitments, aiming to reduce its Scope 1 and Scope 2 greenhouse gas emissions by 46% by 2030, using 2019 as the base year. This target has been validated by the Science Based Targets initiative (SBTi) and aligns with the goal of limiting global warming to 1.5°C. The company is also committed to measuring and reducing its Scope 3 emissions, reflecting a comprehensive approach to tackling its carbon footprint. Overall, PharmLog Pharma Logistik is actively working towards significant emissions reductions, demonstrating its commitment to sustainability and climate responsibility within the healthcare sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Scope 1 | 332,000,000 | 000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
| Scope 2 | 304,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 348,000,000 | 000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pharmlog Pharma Logistik is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
